Chiral Chemistry Enables Firms To Try New Twists On Old Drugs

Sidebar: New Ways To Separate Enantiomers Photo: Malboro Photo SUCCESS IN SEPARATION: Sepracor researchers found that the S-enantiomer of Prozac worked well in preventing migraine, says Dean Handley. A trend in the pharmaceutical industry toward increasing use of chiral chemistry techniques is leading to safer new drugs, while coaxing novel uses from existing blockbuster compounds. These techniques separate drugs that occur in two mirror-image molecular forms, called enantiomers. Louis Pasteur

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Sidebar: New Ways To Separate Enantiomers


INTRICATE ROLES: Louisiana State's Isiah Warner notes that determining the side effects of enantiomers is not always a straightforward task.
Unraveling the roles of enantiomers is not always straightforward. "In many cases, the mirror-image enantiomer of an active compound is innocuous. In other cases, it may be extremely toxic and cause side effects. And together, the enantiomers might produce effects that are not common to either alone," says Isiah Warner, chairman of the chemistry department at Louisiana State University in Baton Rouge.

Developing racemic (mixed-enantiomer) drugs is on the way out, industry analysts say, because pharmaceutical companies must evaluate the individual enantiomers and the combination. "Nearly every pharmaceutical company we deal with doesn't even talk about using a racemate, because it costs more to develop. The company has to put three products through clinical trials, not one," explains Roger Pettman, vice president for sales ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ricki Lewis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide